HR 4106 United States House · 118th Congress

Test Strip Access Act of 2023

This bill amends the 21st Century Cures Act to allow states and tribes to use federal grant funds for fentanyl and xylazine test strips. It directly affects state and tribal programs receiving opioid response funding under the Cures Act, enabling them to cover these drug testing strips. The key provision adds "fentanyl or xylazine test strips" to the list of eligible items that can be purchased with existing grant money. This change makes it easier for local programs to access tools that detect dangerous opioids in illicit drugs, without creating new funding. The bill focuses on expanding current grant flexibility, not changing broader opioid policy.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2023
Committee Review
Floor Vote
President
Introduced Jun 14, 2023 Last action Jun 16, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jun 16, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jun 14, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 14, 2023
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors